GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $529,000 | -63.4% | 7,769 | -84.3% | 0.07% | -61.3% |
| Q4 2021 | $1,444,000 | -14.7% | 49,327 | -25.7% | 0.18% | +5.2% |
| Q3 2021 | $1,692,000 | +635.7% | 66,402 | +910.4% | 0.17% | +561.5% |
| Q2 2021 | $230,000 | -17.6% | 6,572 | +14.2% | 0.03% | -31.6% |
| Q3 2019 | $279,000 | +22.9% | 5,756 | +33.9% | 0.04% | +65.2% |
| Q1 2019 | $227,000 | +25.4% | 4,298 | -60.6% | 0.02% | +130.0% |
| Q2 2016 | $181,000 | – | 10,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |